ID: ALA179197

Max Phase: Preclinical

Molecular Formula: C19H16O5

Molecular Weight: 324.33

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): SCH-68631
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCCC(=O)c1cc2c(c(O)c1C)C(=O)C(=O)c1c(O)cccc1-2

    Standard InChI:  InChI=1S/C19H16O5/c1-3-5-13(20)11-8-12-10-6-4-7-14(21)15(10)18(23)19(24)16(12)17(22)9(11)2/h4,6-8,21-22H,3,5H2,1-2H3

    Standard InChI Key:  YJQYHFMKGAVKDP-UHFFFAOYSA-N

    Associated Targets(Human)

    Catenin beta-1 517 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    TCF4-CTNNB1 complex 25 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HCT-116 91556 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    NS3 1121 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 324.33Molecular Weight (Monoisotopic): 324.0998AlogP: 3.44#Rotatable Bonds: 3
    Polar Surface Area: 91.67Molecular Species: NEUTRALHBA: 5HBD: 2
    #RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 7.69CX Basic pKa: CX LogP: 4.83CX LogD: 4.63
    Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: 1.01

    References

    1. Gordon CP, Keller PA..  (2005)  Control of hepatitis C: a medicinal chemistry perspective.,  48  (1): [PMID:15633995] [10.1021/jm0400101]
    2. Dai J, Carté BK, Sidebottom PJ, Sek Yew AL, Ng S, Huang Y, Butler MS..  (2001)  Circumdatin G, a new alkaloid from the fungus Aspergillus ochraceus.,  64  (1): [PMID:11170686] [10.1021/np000381u]
    3. Hahne G, Grossmann TN..  (2013)  Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling.,  21  (14): [PMID:23566764] [10.1016/j.bmc.2013.02.050]
    4. Radwan AA, Al-Mohanna F, Alanazi FK, Manogaran PS, Al-Dhfyan A..  (2016)  Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides.,  26  (7): [PMID:26944615] [10.1016/j.bmcl.2016.02.064]
    5. Phull MS, Jadav SS, Gundla R, Mainkar PS..  (2021)  A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.,  212  [PMID:33445154] [10.1016/j.ejmech.2020.113149]

    Source